The Settlement of Protonix® Patent Litigation in the U.S.
I hope no one is still thinking Takeda is going to use the funds from this settlement to buy Affy. This is from Takeda's site:
Pfizer and Takeda will share the proceeds of the settlement, and, it should be noted that Takeda’s acquisition of Nycomed in 2011 excluded proceeds from this litigation and, therefore, all the proceeds to be received by Takeda from Teva and Sun will be forwarded to the former owners of Nycomed.
"NYCOMED IS NOW PART OF TAKEDA"....I couldn't find anything on your post other than this so please provide original sources!!! Not that this matters, because what I said was that Takeda was waiting for this settlement and it could potentially be used to support Affymax acquisition...In a company, money is FUNGIBLE!!!
Pfizer Inc. Research Report
On June 12, 2013, Pfizer Inc. (Pfizer) announced that it has reached a $2.15 billion settlement with Teva Pharmaceuticals and Sun Pharmaceuticals for patent-infringement damages related to the launches of the generic Protonix in the US. Amy W. Schulman, Executive Vice President and General Counsel of Pfizer, said, "We are pleased with today's settlement, which recognizes the validity and value of the innovation that led to Protonix." Schulman added, "Protecting intellectual property is vital as we develop new medicines that save and enhance patients' lives." Pfizer will receive 64% of the compensation, and the remaining will be given to Nycomed, which is now part of Takeda.
BTW, whether or not your report is correct...IF correct it certainly would demonstrate how Takeda takes care of acquisition's original shareholders and I am good with that interpretation as well...it would bode well for how they will deal with Affymax shareholders either way :-)